[Management of paroxysmal tachycardia].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000404:Ajmaline / Q000627:therapeutic use; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004554:Electric Countershock; D006801:Humans; D008274:Magnesium / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009570:Nitriles / Q000627:therapeutic use; D011188:Potassium / Q000627:therapeutic use; D011342:Procainamide / Q000627:therapeutic use; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy / Q000628:therapy*
D000319:Adrenergic beta-Antagonists; D004071:Digitalis Glycosides; D009570:Nitriles; D000404:Ajmaline; D008274:Magnesium; D011342:Procainamide; D011188:Potassium
Behandlung der paroxysmalen Tachykardie.